Literature DB >> 8587237

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis.

M Ruiz-Ortega1, S González, D Serón, E Condom, C Bustos, R Largo, E González, A Ortiz, J Egido.   

Abstract

We studied the effect of the angiotensin converting enzyme (ACE) inhibitor, quinapril, on the clinical and morphological lesions of a normotensive model of immune complex nephritis. Untreated rats developed massive nephrotic syndrome, intense cell proliferation and glomerular and tubulointerstitial lesions. In the renal cortex of nephritic rats there was a significant increase in gene expression of TGF-beta 1, fibronectin and collagens, and ACE activity. Systolic blood pressure remained normal with progression of the disease. Administration of quinapril for three weeks to animals with glomerular lesions (proteinuria 20 to 50 mg/day) avoided the development of intense proteinuria (79 +/- 28 vs. 589 +/- 73 mg/day, P < 0.001) and decreased cell proliferation, glomerulosclerosis, tubulointerstitial lesions, and inflammatory infiltrates. Cortical gene expression of TGF-beta 1 and matrix proteins was also diminished. ACE activity was inhibited by 68% in renal cortex. These results show that quinapril administration to normotensive rats with immune complex nephritis decreases proteinuria and glomerular and tubulointerstitial lesions, probably modulating the local angiotensin II generation and its effects on cell growth, TGF beta and matrix protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587237     DOI: 10.1038/ki.1995.476

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness.

Authors:  J Rincón; G Parra; Y Quiroz; L Benatuil; B Rodríguez-Iturbe
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Regulation of matrix proteins and impact on vascular structure.

Authors:  J Tuñón; M Ruiz-Ortega; J Egido
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

3.  Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.

Authors:  Y Hisada; T Sugaya; M Yamanouchi; H Uchida; H Fujimura; H Sakurai; A Fukamizu; K Murakami
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors.

Authors:  M Ruiz-Ortega; O Lorenzo ; M Rupérez; J Blanco; J Egido
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Liver angiotensinogen is the primary source of renal angiotensin II.

Authors:  Taiji Matsusaka; Fumio Niimura; Akihiro Shimizu; Ira Pastan; Akihiko Saito; Hiroyuki Kobori; Akira Nishiyama; Iekuni Ichikawa
Journal:  J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 10.121

6.  Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Authors:  Taiji Matsusaka; Fumio Niimura; Ira Pastan; Ayumi Shintani; Akira Nishiyama; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

7.  Angiotensin II increases connective tissue growth factor in the kidney.

Authors:  Monica Rupérez; Marta Ruiz-Ortega; Vanesa Esteban; Oscar Lorenzo; Sergio Mezzano; Juan Jose Plaza; Jesús Egido
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction.

Authors:  Mirjana Kostić; Aleksandra Stanković; Maja Zivković; Amira Peco-Antić; Olga Jovanović; Dragan Alavantić; Divna Kruscić
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

9.  An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

Authors:  Deijanira Alves De Albuquerque; Vijay Saxena; David E Adams; Gregory P Boivin; Hermine I Brunner; David P Witte; Ram Raj Singh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

Review 10.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.